Talis Biomedical Corporation Selling, General and Administrative Expense
Talis Biomedical Corporation reported Selling, General and Administrative Expense of $7.98 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2024-08-19
- Talis Biomedical Corporation selling, general and administrative expense for the quarter ending 2024-06-30 was $7.98M, a 24.45% increase year-over-year.
- Talis Biomedical Corporation selling, general and administrative expense for the quarter ending 2024-03-31 was $11.65M, a 82.08% increase year-over-year.
- Talis Biomedical Corporation selling, general and administrative expense for the quarter ending 2023-12-31 was $6.60M, a 38.85% decline year-over-year.
- Talis Biomedical Corporation selling, general and administrative expense for the quarter ending 2023-09-30 was $8.80M, a 0.25% decline year-over-year.
- Talis Biomedical Corporation selling, general and administrative expense for fiscal 2023 was $28.21M, a 30.73% decline from fiscal 2022.
- Talis Biomedical Corporation selling, general and administrative expense for fiscal 2022 was $40.73M, a 3.98% decline from fiscal 2021.
- Talis Biomedical Corporation selling, general and administrative expense for fiscal 2021 was $42.42M, a 223.73% increase from fiscal 2020.
- Talis Biomedical Corporation selling, general and administrative expense for fiscal 2020 was $13.10M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $7.98M 10-Q · filed 2024-08-19 | $19.63M 10-Q · filed 2024-08-19 | $26.23M derived: sum of 3 quarters · filed 2024-08-19 | $35.03M derived: sum of 4 quarters · filed 2024-08-19 |
| 2024-03-31 | $11.65M 10-Q · filed 2024-05-08 | $18.25M derived: sum of 2 quarters · filed 2024-05-08 | $27.06M derived: sum of 3 quarters · filed 2024-05-08 | $33.47M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-12-31 | $6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $15.40M derived: sum of 2 quarters · filed 2024-03-28 | $21.82M derived: sum of 3 quarters · filed 2024-08-19 | $28.21M 10-K · filed 2024-03-28 |
| 2023-09-30 | $8.80M 10-Q · filed 2023-11-14 | $15.21M derived: sum of 2 quarters · filed 2024-08-19 | $21.61M 10-Q · filed 2023-11-14 | $32.41M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-06-30 | $6.41M 10-Q · filed 2024-08-19 | $12.81M 10-Q · filed 2024-08-19 | $23.61M derived: sum of 3 quarters · filed 2024-08-19 | $32.43M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $6.40M 10-Q · filed 2024-05-08 | $17.20M derived: sum of 2 quarters · filed 2024-05-08 | $26.02M derived: sum of 3 quarters · filed 2024-05-08 | $35.20M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $10.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $19.62M derived: sum of 2 quarters · filed 2024-03-28 | $28.80M derived: sum of 3 quarters · filed 2024-03-28 | $40.73M 10-K · filed 2024-03-28 |
| 2022-09-30 | $8.82M 10-Q · filed 2023-11-14 | $18.00M derived: sum of 2 quarters · filed 2023-11-14 | $29.93M 10-Q · filed 2023-11-14 | $42.25M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $9.18M 10-Q · filed 2023-08-10 | $21.11M 10-Q · filed 2023-08-10 | $33.42M derived: sum of 3 quarters · filed 2023-08-10 | $46.22M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $11.93M 10-Q · filed 2023-05-11 | $24.25M derived: sum of 2 quarters · filed 2023-05-11 | $37.04M derived: sum of 3 quarters · filed 2023-05-11 | $47.02M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $12.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $25.11M derived: sum of 2 quarters · filed 2023-03-22 | $35.09M derived: sum of 3 quarters · filed 2023-03-22 | $42.42M 10-K · filed 2023-03-22 |
| 2021-09-30 | $12.79M 10-Q · filed 2022-11-03 | $22.77M derived: sum of 2 quarters · filed 2022-11-03 | $30.10M 10-Q · filed 2022-11-03 | $35.41M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $9.98M 10-Q · filed 2022-08-02 | $17.31M 10-Q · filed 2022-08-02 | $22.61M derived: sum of 3 quarters · filed 2022-08-02 | $25.67M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $7.33M 10-Q · filed 2022-05-10 | $12.63M derived: sum of 2 quarters · filed 2022-05-10 | $15.69M derived: sum of 3 quarters · filed 2022-05-10 | $18.35M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $8.36M derived: sum of 2 quarters · filed 2022-03-15 | $11.02M derived: sum of 3 quarters · filed 2022-03-15 | $13.10M 10-K · filed 2022-03-15 |
| 2020-09-30 | $3.06M 10-Q · filed 2021-11-16 | $5.72M derived: sum of 2 quarters · filed 2021-11-16 | $7.80M 10-Q · filed 2021-11-16 | |
| 2020-06-30 | $2.66M 10-Q · filed 2021-08-10 | $4.74M 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $2.08M 10-Q · filed 2021-05-13 |